Light exposure stimulates formation of A2E oxiranes in a mouse model of Stargardt's macular degeneration
- PMID: 15067110
- PMCID: PMC395900
- DOI: 10.1073/pnas.0308302101
Light exposure stimulates formation of A2E oxiranes in a mouse model of Stargardt's macular degeneration
Abstract
Recessive Stargardt's macular degeneration is a blinding disease of children caused by mutations in the ABCA4 (ABCR) gene. Mice with a knockout mutation in abcr accumulate toxic lipofuscin pigments in ocular tissues, similar to affected humans. The major fluorophore of lipofuscin is the bis-retinoid, N-retinylidene-N-retinylethanolamine (A2E). In the current study, we sought to define the effect of increasing light on A2E accumulation. We crossed the abcr(-/-) mutation onto an albino background. The retinoid profiles in albino mice indicated higher retinal illuminance than in pigmented mice exposed to similar ambient light. Unexpectedly, A2E levels were not higher in the albino mice. Also, A2E levels in abcr(-/-) mice reared under cyclic light at 30, 120, or 1,700 lux were similar. Thus, increased retinal illuminance was not correlated with higher A2E. A2E has been shown to undergo light-dependent oxidation to yield a series of A2E epoxides or oxiranes. These oxiranes react with DNA in vitro, suggesting a potential mechanism for A2E cytotoxicity. We analyzed ocular tissues from abcr(-/-) mice for A2E oxiranes by mass spectrometry. Unlike A2E, the oxiranes were more abundant in albino vs. pigmented abcr(-/-) mice, and in abcr(-/-) mice exposed to increasing ambient light. These observations suggest that both the biosynthesis of A2E and its conversion to oxiranes are accelerated by light. Finally, we showed that the formation of A2E oxiranes is strongly suppressed by treating the abcr(-/-) mice with Accutane (isotretinoin), an inhibitor of rhodopsin regeneration.
Figures







Similar articles
-
Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration.Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4742-7. doi: 10.1073/pnas.0737855100. Epub 2003 Apr 1. Proc Natl Acad Sci U S A. 2003. PMID: 12671074 Free PMC article.
-
Isotretinoin treatment inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration.Novartis Found Symp. 2004;255:51-63; discussion 63-7, 177-8. Novartis Found Symp. 2004. PMID: 14750596
-
Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration.Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7154-9. doi: 10.1073/pnas.130110497. Proc Natl Acad Sci U S A. 2000. PMID: 10852960 Free PMC article.
-
Stargardt's disease and the ABCR gene.Semin Ophthalmol. 2008 Jan-Feb;23(1):59-65. doi: 10.1080/08820530701745249. Semin Ophthalmol. 2008. PMID: 18214793 Review.
-
Macular Pigment Carotenoids and Bisretinoid A2E.Adv Exp Med Biol. 2023;1415:15-20. doi: 10.1007/978-3-031-27681-1_3. Adv Exp Med Biol. 2023. PMID: 37440008 Review.
Cited by
-
Arrestin can act as a regulator of rhodopsin photochemistry.Vision Res. 2006 Dec;46(27):4532-46. doi: 10.1016/j.visres.2006.08.031. Epub 2006 Oct 27. Vision Res. 2006. PMID: 17069872 Free PMC article.
-
Morphological and physiological retinal degeneration induced by intravenous delivery of vitamin A dimers in rabbits.Dis Model Mech. 2015 Feb;8(2):131-8. doi: 10.1242/dmm.017194. Epub 2014 Dec 12. Dis Model Mech. 2015. PMID: 25504631 Free PMC article.
-
Retinoids for treatment of retinal diseases.Trends Pharmacol Sci. 2010 Jun;31(6):284-95. doi: 10.1016/j.tips.2010.03.001. Trends Pharmacol Sci. 2010. PMID: 20435355 Free PMC article. Review.
-
Complement system dysregulation and inflammation in the retinal pigment epithelium of a mouse model for Stargardt macular degeneration.J Biol Chem. 2011 May 27;286(21):18593-601. doi: 10.1074/jbc.M110.191866. Epub 2011 Apr 4. J Biol Chem. 2011. PMID: 21464132 Free PMC article.
-
Stargardt's Disease: Molecular Pathogenesis and Current Therapeutic Landscape.Int J Mol Sci. 2025 Jul 21;26(14):7006. doi: 10.3390/ijms26147006. Int J Mol Sci. 2025. PMID: 40725253 Free PMC article. Review.
References
-
- Lee, B. L. & Heckenlively, J. R. (1999) in Retina-Vitreous-Macula, eds. Guyer, D. R., Yannuzzi, L. A., Chang, S., Shields, J. A. & Green, W. R. (Saunders, Darien, IL), pp. 978–988.
-
- Eagle, R. C., Jr., Lucier, A. C., Bernardino, V. B., Jr., & Yanoff, M. (1980) Ophthalmology 87, 1189–1200. - PubMed
-
- Birnbach, C. D., Jarvelainen, M., Possin, D. E. & Milam, A. H. (1994) Ophthalmology 101, 1211–1219. - PubMed
-
- Steinberg, R. H. (1985) Doc. Ophthalmol. 60, 327–346. - PubMed
-
- Weng, J., Mata, N. L., Azarian, S. M., Tzekov, R. T., Birch, D. G. & Travis, G. H. (1999) Cell 98, 13–23. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous